1. Home
  2. QTRX vs ACV Comparison

QTRX vs ACV Comparison

Compare QTRX & ACV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTRX
  • ACV
  • Stock Information
  • Founded
  • QTRX 2007
  • ACV 2015
  • Country
  • QTRX United States
  • ACV United States
  • Employees
  • QTRX N/A
  • ACV N/A
  • Industry
  • QTRX Biotechnology: Laboratory Analytical Instruments
  • ACV Finance/Investors Services
  • Sector
  • QTRX Industrials
  • ACV Finance
  • Exchange
  • QTRX Nasdaq
  • ACV Nasdaq
  • Market Cap
  • QTRX 233.5M
  • ACV 229.2M
  • IPO Year
  • QTRX 2017
  • ACV N/A
  • Fundamental
  • Price
  • QTRX $6.12
  • ACV $21.94
  • Analyst Decision
  • QTRX Buy
  • ACV
  • Analyst Count
  • QTRX 5
  • ACV 0
  • Target Price
  • QTRX $15.60
  • ACV N/A
  • AVG Volume (30 Days)
  • QTRX 763.5K
  • ACV 38.8K
  • Earning Date
  • QTRX 08-07-2025
  • ACV 01-01-0001
  • Dividend Yield
  • QTRX N/A
  • ACV 9.20%
  • EPS Growth
  • QTRX N/A
  • ACV N/A
  • EPS
  • QTRX N/A
  • ACV N/A
  • Revenue
  • QTRX $135,688,000.00
  • ACV N/A
  • Revenue This Year
  • QTRX N/A
  • ACV N/A
  • Revenue Next Year
  • QTRX $14.49
  • ACV N/A
  • P/E Ratio
  • QTRX N/A
  • ACV N/A
  • Revenue Growth
  • QTRX 7.71
  • ACV N/A
  • 52 Week Low
  • QTRX $4.05
  • ACV $16.82
  • 52 Week High
  • QTRX $16.74
  • ACV $23.74
  • Technical
  • Relative Strength Index (RSI)
  • QTRX 55.97
  • ACV 54.70
  • Support Level
  • QTRX $5.98
  • ACV $21.74
  • Resistance Level
  • QTRX $6.76
  • ACV $22.05
  • Average True Range (ATR)
  • QTRX 0.52
  • ACV 0.24
  • MACD
  • QTRX 0.09
  • ACV -0.11
  • Stochastic Oscillator
  • QTRX 56.46
  • ACV 21.11

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest

Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It invests in a diversified portfolio of convertible securities, income-producing equity securities, and income-producing debt and other instruments of varying maturities, of which a majority of the managed assets are invested in convertibles.

Share on Social Networks: